These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 7339498)
21. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta. Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975 [TBL] [Abstract][Full Text] [Related]
22. [Leptospira infected rat population as probable cause of a fatal case of Weil's disease]. Brem S; Radu O; Bauer T; Schönberg A; Reisshauer K; Waidmann R; Kopp H; Meyer P Berl Munch Tierarztl Wochenschr; 1995 Nov; 108(11):405-7. PubMed ID: 8593131 [TBL] [Abstract][Full Text] [Related]
23. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model. Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185 [TBL] [Abstract][Full Text] [Related]
24. Experimental studies comparing iohexol and 51Cr-EDTA for glomerular filtration rate measurements. Lundqvist S; Hietala SO; Karp K Acta Radiol; 1995 Jan; 36(1):58-63. PubMed ID: 7833170 [TBL] [Abstract][Full Text] [Related]
25. NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins. Blasi E; Ardizzoni A; Colombari B; Neglia R; Baschieri C; Peppoloni S; Cinco M Microb Pathog; 2007; 42(2-3):80-7. PubMed ID: 17189679 [TBL] [Abstract][Full Text] [Related]
26. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha. Nishihara K; Barth RF; Wilkie N; Lang JC; Oda Y; Kikuchi H; Everson MP; Lotze MT Cancer Gene Ther; 1995 Jun; 2(2):113-24. PubMed ID: 7621259 [TBL] [Abstract][Full Text] [Related]
27. Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection. Schirrmacher V; Haas C; Bonifer R; Ertel C Clin Cancer Res; 1997 Jul; 3(7):1135-48. PubMed ID: 9815793 [TBL] [Abstract][Full Text] [Related]
28. Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases. Kaido TJ; Maury C; Gresser I Cancer Res; 1995 Dec; 55(24):6133-9. PubMed ID: 8521404 [TBL] [Abstract][Full Text] [Related]
29. Evidence for passing down of postnasal drip into respiratory organs. Kogahara T; Kanai K; Asano K; Suzaki H In Vivo; 2009; 23(2):297-301. PubMed ID: 19414418 [TBL] [Abstract][Full Text] [Related]
30. Immunotherapy of the SL2-5 murine lymphoma with natural killer cells and tamoxifen or toremifene. Baral E; Nagy E; Kangas L; Berczi I Anticancer Res; 1997; 17(1A):77-83. PubMed ID: 9066633 [TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of transplantable tumors in mice by mIL-2-secreting murine plasmocytoma cells used alone or in combination with a cytostatic agent. Pajtasz-Piasecka E; Kuśnierczyk H; Salwa J; Konarski L; Radzikowski C Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):281-92. PubMed ID: 8744648 [TBL] [Abstract][Full Text] [Related]
32. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. Luo JC; Toyoda M; Shibuya M Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584 [TBL] [Abstract][Full Text] [Related]
33. Use of the enriched stable isotope Cr-50 as a tracer to study the metabolism of chromium (III) in normal and diabetic rats. Feng W; Ding W; Qian Q; Chai Z Biol Trace Elem Res; 1998 Aug; 63(2):129-38. PubMed ID: 9823439 [TBL] [Abstract][Full Text] [Related]
34. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors. Luo JC; Yamaguchi S; Shinkai A; Shitara K; Shibuya M Cancer Res; 1998 Jun; 58(12):2652-60. PubMed ID: 9635593 [TBL] [Abstract][Full Text] [Related]
35. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation? Magnusson KP; Satalino R; Qian W; Klein G; Wiman KG Oncogene; 1998 Nov; 17(18):2333-7. PubMed ID: 9811464 [TBL] [Abstract][Full Text] [Related]
37. Red cell volume determination using a stable isotope of chromium. Silver HM; Seebeck MA; Cowett RM; Patterson KY; Veillon C J Soc Gynecol Investig; 1997; 4(5):254-8. PubMed ID: 9360230 [TBL] [Abstract][Full Text] [Related]
38. The fate of L-1210 leukemia cells labelled with radiochromium (51Cr) in the perfused mouse liver. Skierski JS; Doroszewski J; Lezoń T Leuk Res; 1979; 3(3):153-62. PubMed ID: 470432 [No Abstract] [Full Text] [Related]
39. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Darro F; Decaestecker C; Gaussin JF; Mortier S; Van Ginckel R; Kiss R Int J Oncol; 2005 Sep; 27(3):607-16. PubMed ID: 16077908 [TBL] [Abstract][Full Text] [Related]
40. Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein. Bian H; Fournier P; Peeters B; Schirrmacher V Int J Oncol; 2005 Aug; 27(2):377-84. PubMed ID: 16010418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]